Page last updated: 2024-12-10

disuccinimidyl glutarate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID4432628
SCHEMBL ID34383
MeSH IDM0253829

Synonyms (26)

Synonym
di(n-succinimidyl) glutarate, >=97.0% (chn)
bis(2,5-dioxopyrrolidin-1-yl) pentanedioate
79642-50-5
di(n-succinimidyl) glutarate
disuccinimidyl glutarate
FT-0625347
AKOS015915854
pentanedioic acid,1,5-bis(2,5-dioxo-1-pyrrolidinyl) ester
LNQHREYHFRFJAU-UHFFFAOYSA-N
SCHEMBL34383
dsg crosslinker
BP-22659
DTXSID30403242
mfcd00153597
GS-5702
di(n-hydroxysuccinimidyl) glutarate
A904444
bis(2,5-dioxopyrrolidin-1-yl) glutarate
CS-0064111
HY-114697
disuccinimidyl glutarate;di(n-succinimidyl) glutarate
F11369
disuccinimidylglutarate
LCZC1067
di(n-succinimidyl) glutarate dsg
c13h14n2o8
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's7 (38.89)18.2507
2000's8 (44.44)29.6817
2010's3 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.97 (24.57)
Research Supply Index3.00 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index35.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (5.26%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other18 (94.74%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]